On Demand 2018 Name That Rash: Serious Drug Rashes and Others (MOC)

Price: $25 members, $35 non-members

Drug-induced rashes are common. Most are benign and resolve shortly after discontinuation of the drug, but certain drug rashes are associated with high risk of morbidity and mortality and must be recognized early and treated promptly.

You can earn up to 1.5 AMA PRA Category 1 Credits™, and up to 1.5 MOC Part II Self-Assessment credits. 

  • Introduction to Drug Allergy and Benign Skin Rashes
    Aleena Banerji, MD
  • Contact-induced Drug Eruptions and System Contact Dermatitis
    Luz S. Fonacier, MD, FACAAI
  • Life-threatening and Systemic Drug Reactions
    Robert Sidbury, MD, MPH

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Of the AMA PRA Category 1 Credits™ listed above, the ABAI has designated a maximum of 1.5 credits as meeting the requirements for MOC Part II Self-Assessment.

Target Audience

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

  • Recognize drug-induced rashes associated with high risk of morbidity and mortality.
  • Identify specific treatments for certain serious drug rashes.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (College) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, or evaluation of content for a CME activity. Financial disclosures are reviewed in advance, to ensure any potential conflicts of interest are resolved. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Specific disclosure information for the 2018 Annual Meeting is now available online.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 MOC
Course opens: 
12/07/2018
Course expires: 
12/06/2021
Cost:
$35.00
Rating: 
0

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 MOC

Accreditation Period

Course opens: 
12/07/2018
Course expires: 
12/06/2021

Price

Cost:
$35.00
Please login or create an account to take this course.